Integrating pharmacokinetics and network analysis to investigate the mechanism of Moutan Cortex in blood-heat and blood stasis syndrome

Author:

Ye Qiuli,Zhang Ying,Yan Donghui,Sun Yue,Li Ming,Cao Hui,Wang Shumei,Meng Jiang

Abstract

Abstract Background Raw Moutan Cortex (RMC) has been used in China and other Asian countries for thousands of years. Its medical application is the treatment of cooling blood and promoting blood circulation. However, its therapeutic mechanism is still undefined. Methods In this study, the pharmacokinetics strategy that integrated network analysis was employed to explore the mechanism of RMC in blood-heat and blood stasis syndrome (BHS) model rats. Firstly, Ultra-High performance Liquid Chromatography coupled with Diode Array Detector (UHPLC-DAD) method was developed to determine nine absorbed compounds in rat serum in BHS and normal rats after oral administration of RMC extract respectively. Then the pharmacology network was established based on the relationship between nine compounds absorbed into the blood and BHS targets. Finally, the predicted hub targets were validated experimentally in human umbilical vein endothelial cells (HUVECs). Results Pharmacokinetic study showed that the pharmacokinetic parameters of nine absorbed compounds had significant differences between BHS and normal groups (p < 0.05). Network analysis showed that 8 target genes, namely, F2, F10, F7, PLAU, MAPK14, MAPK10, AKT1, and NOS3 may be the primary targets regulated by RMC for the treatment of BHS. Among them, targets (F2, F10, F7 and MAPK14, MAPK10, AKT) and 4 active ingredients (paeonol, paeoniflorin, quercetin and oxypaeoniflorin) were selected for evaluating the reliability in vitro experiments, which revealed that the mechanism of RMC against BHS syndrome may inhibit inflammatory pathways and regulate coagulation cascades pathway for cooling and promoting blood circulation. Conclusion The proposed pharmacokinetics study integrated network analysis strategy provides a combination method to explore the therapeutic mechanism of RMC on BHS. Graphical Abstract

Funder

National Natural Science Foundation of China

the innovation project of Guangdong Province

Guangzhou science and technology planning project

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,Pharmacology

Reference69 articles.

1. Bensky D, Gamble A. Chinese herbal medicine materia medica, revised edition. Seattle: Eastland Press; 1993.

2. Wang J. Study on the pharmacological effects of traditional Chinese medicine for promoting blood circulation and removing stasis. Medicine and Health. 2016;000(004):00106–00106.

3. Gao C, Liu L, Hu A, Feng Y, Zhu L. Research progress on the pharmacological effects of traditional Chinese medicines for promoting blood circulation and removing blood stasis. Drug Eval Res. 2013;36(1):64–8.

4. Committee NP. Pharmacopoeia of the people’s republic of China. Beijing: Chinese Medical Science and Technology Press; 2015.

5. Deng X, Yu J, Ding M, Zhao M, Xue X, Che C, Wang S, Zhao B, Meng J. Liquid chromatography-diode array detector-electrospray mass spectrometry and principal components analyses of raw and processed moutan cortex. Pharmacogn Mag. 2016;12(45):50–6.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3